ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281 | -34.7% | 14,013 | -8.2% | 0.00% | -33.3% |
| Q2 2023 | $430 | +77.7% | 15,258 | +8.5% | 0.00% | +50.0% |
| Q1 2023 | $242 | -12.3% | 14,065 | +2.5% | 0.00% | 0.0% |
| Q4 2022 | $276 | -99.9% | 13,717 | -7.9% | 0.00% | 0.0% |
| Q3 2022 | $323,000 | +53.8% | 14,894 | +99.7% | 0.00% | +100.0% |
| Q2 2022 | $210,000 | -2.3% | 7,460 | +59.8% | 0.00% | 0.0% |
| Q1 2022 | $215,000 | -40.8% | 4,669 | +8.0% | 0.00% | -50.0% |
| Q4 2021 | $363,000 | +67.3% | 4,323 | +32.5% | 0.00% | +100.0% |
| Q3 2021 | $217,000 | – | 3,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
| Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
| Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
| Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
| Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
| Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
| Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
| Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |